European Pharmaceutical Review

JUNE 15, 2023

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. However, the safety and efficacy of these devices can be compromised if they are not appropriately designed, manufactured, and maintained, the authors wrote.

Manufacturing 80

Manufacturing Medical Safety Transportation 80

PharmaKinnex

AUGUST 23, 2022

August 23, 2022. The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Today, in 2022, the industry is changing again, and in some big, exciting ways. More convenience and safety? The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 77

Food and Drug Administration Safety Patients Leads 77